NIH-funded research NIH-funded research

How cells spot and protect DNA when copying goes wrong

Official title: DNA Replication Checkpoint in Fission Yeast

Funded at Wright State University · NIH-11261077 · Data updated 2026-11-12

Using yeast as a model, researchers aim to learn how cells detect and protect DNA during copying errors to help improve cancer treatments.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWright State University
NIH-funded
Lab location1 site (Dayton, United States)
Project startFebruary 1, 2022
Project endJanuary 31, 2027
Funding year2026
Award (this year)$375,000
NIH project number5R35GM144307-05
Project IDNIH-11261077 on NIH RePORTER

Who could benefit from this research

Could help

Patients with cancers treated by DNA-targeting chemotherapy may be most interested in following this research or taking part in future translational studies based on these findings.

Less likely to help

People without cancer or those seeking immediate clinical treatment changes are unlikely to receive direct benefit from this laboratory-focused project.

What this research studies

This lab project uses fission yeast, a simple single-celled organism, to study the DNA replication checkpoint that senses problems during DNA copying. Researchers will perform genetic screens to find yeast mutants with altered checkpoint responses and then use biochemical experiments to determine how checkpoints begin at stalled replication forks and protect fork function under stress. Because many chemotherapy drugs disrupt DNA replication, these experiments may reveal mechanisms that influence how tumors respond to treatment. The work is laboratory-based and does not directly enroll patients, but focuses on processes that are conserved in human cells.

Why it matters

Potential benefit: If successful, the findings could help researchers develop better cancer therapies or predict which tumors will respond to DNA-targeting drugs.

How similar studies have gone: Previous work using yeast has uncovered many DNA repair and checkpoint mechanisms later confirmed in human cells, so the approach is well established even though the specific mutants studied are new.

Where this research is happening

  • Wright State University
    Dayton, United States
    Active

Researchers

  • Principal investigator: Xu, Yongjie — Wright State University
  • Study coordinator: Xu, Yongjie

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.